Lista de obras - Barbara Belletti - Dominio Público Uruguay

A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis

artículo científico publicado en 2013

An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.

artículo científico publicado en 2017

CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation

artículo científico

CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer

artículo científico publicado en 2020

Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells.

artículo científico publicado en 2017

Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner

artículo científico publicado en 2014

Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid gland

scientific journal article

Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer

artículo científico publicado en 2019

Efficient in vitro and in vivo gene regulation of a retrovirally delivered pro-apoptotic factor under the control of the Drosophila HSP70 promoter.

artículo científico publicado en 2001

Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development.

artículo científico publicado en 2007

HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel

artículo científico publicado en 2022

HMGA1 protein expression sensitizes cells to cisplatin-induced cell death

artículo científico publicado en 2005

Identification and Characterization of a New Platinum-Induced TP53 Mutation in MDAH Ovarian Cancer Cells

artículo científico publicado en 2019

Inhibition of breast cancer local relapse by targeting p70S6 kinase activity

artículo científico publicado en 2013

Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib

artículo científico publicado en 2016

Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation.

artículo científico publicado en 1999

Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors

artículo científico publicado en 2018

Linking inflammation to cell cycle progression.

artículo científico publicado en 2004

Loss of p27kip1 increases genomic instability and induces radio-resistance in luminal breast cancer cells.

artículo científico publicado en 2017

Meet me in the cytoplasm: A role for p27(Kip1) in the control of H-Ras.

artículo científico publicado en 2016

Molecular biology of breast tumors and prognosis

artículo científico publicado en 2016

Negative Regulation of BRCA1 Gene Expression by HMGA1 Proteins Accounts for the Reduced BRCA1 Protein Levels in Sporadic Breast Carcinoma

artículo científico publicado en 2003

New light on p27(kip1) in breast cancer

artículo científico publicado en 2012

Nuclear translocation of insulin receptor substrate-1 by oncogenes and Igf-I. Effect on ribosomal RNA synthesis

artículo científico publicado en 2002

Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells

artículo científico publicado en 1999

Post-transcriptional regulation of thromboxane A2 synthase in U937 cells.

artículo científico publicado en 1995

Preclinical validation of a novel compound targeting p70S6 kinase in breast cancer.

artículo científico publicado en 2016

Prostacyclin (PGI2) synthase is a constitutively expressed enzyme in human endothelial cells.

artículo científico publicado en 1995

Protein tyrosine phosphatase-eta expression is upregulated by the PKA-dependent and is downregulated by the PKC-dependent pathways in thyroid cells.

artículo científico publicado en 1998

RNA splicing alteration in the response to platinum chemotherapy in ovarian cancer: A possible biomarker and therapeutic target

artículo científico publicado en 2020

Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.

artículo científico publicado en 2016

Regulation of Id1 protein expression in mouse embryo fibroblasts by the type 1 insulin-like growth factor receptor.

artículo científico publicado en 2002

Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling by phosphatidylinositol 3-kinase.

artículo científico publicado en 2001

Regulation of thymosin beta10 expression by TSH and other mitogenic signals in the thyroid gland and in cultured thyrocytes

artículo científico publicado en 1999

Role of T198 modification in the regulation of p27(Kip1) protein stability and function

artículo científico publicado en 2011

Roles of CDKN1B in cancer?

artículo científico publicado en 2015

STAT3 in Breast Cancer Onset and Progression: A Matter of Time and Context

scientific article published on 18 September 2018

SUMOylation regulates p27Kip1 stability and localization in response to TGFβ.

artículo científico publicado en 2015

Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition.

artículo científico publicado en 2014

Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells

artículo científico publicado en 2020

Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity

artículo científico publicado en 2020

Stathmin Is Required for Normal Mouse Mammary Gland Development and Δ16HER2-Driven Tumorigenesis

artículo científico publicado en 2018

Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.

artículo científico publicado en 2008

Stathmin is dispensable for tumor onset in mice

artículo científico publicado en 2012

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer.

artículo científico publicado en 2013

Stathmin: a protein with many tasks. New biomarker and potential target in cancer

artículo científico

Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding

artículo científico publicado en 2008

The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition.

artículo científico publicado en 2009

Thromboxane A2 synthase activity in platelet free human monocytes

artículo científico publicado en 1994

Time-tuning cancer therapy.

artículo científico publicado en 2015

USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability

scientific article published on 08 May 2019

p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion

scientific journal article

p27(kip1) functional regulation in human cancer: a potential target for therapeutic designs.

artículo científico publicado en 2005

p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis.

artículo científico publicado en 2008

p27kip1 at the crossroad between actin and microtubule dynamics

scientific article published on 01 April 2019

p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability.

artículo científico publicado en 2015

p27kip1 expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanisms.

artículo científico publicado en 2016

p27kip1: An all-round tumor suppressor

artículo científico publicado en 2016

p70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation.

artículo científico publicado en 2014

Lista de obras de Barbara Belletti

A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis

An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.

CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation

CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer

Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells.

Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner

Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid gland

Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer

Efficient in vitro and in vivo gene regulation of a retrovirally delivered pro-apoptotic factor under the control of the Drosophila HSP70 promoter.

Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development.

HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel

HMGA1 protein expression sensitizes cells to cisplatin-induced cell death

Identification and Characterization of a New Platinum-Induced TP53 Mutation in MDAH Ovarian Cancer Cells

Inhibition of breast cancer local relapse by targeting p70S6 kinase activity

Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib

Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation.

Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors

Linking inflammation to cell cycle progression.

Loss of p27kip1 increases genomic instability and induces radio-resistance in luminal breast cancer cells.

Meet me in the cytoplasm: A role for p27(Kip1) in the control of H-Ras.

Molecular biology of breast tumors and prognosis

Negative Regulation of BRCA1 Gene Expression by HMGA1 Proteins Accounts for the Reduced BRCA1 Protein Levels in Sporadic Breast Carcinoma

New light on p27(kip1) in breast cancer

Nuclear translocation of insulin receptor substrate-1 by oncogenes and Igf-I. Effect on ribosomal RNA synthesis

Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells

Post-transcriptional regulation of thromboxane A2 synthase in U937 cells.

Preclinical validation of a novel compound targeting p70S6 kinase in breast cancer.

Prostacyclin (PGI2) synthase is a constitutively expressed enzyme in human endothelial cells.

Protein tyrosine phosphatase-eta expression is upregulated by the PKA-dependent and is downregulated by the PKC-dependent pathways in thyroid cells.

RNA splicing alteration in the response to platinum chemotherapy in ovarian cancer: A possible biomarker and therapeutic target

Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.

Regulation of Id1 protein expression in mouse embryo fibroblasts by the type 1 insulin-like growth factor receptor.

Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling by phosphatidylinositol 3-kinase.

Regulation of thymosin beta10 expression by TSH and other mitogenic signals in the thyroid gland and in cultured thyrocytes

Role of T198 modification in the regulation of p27(Kip1) protein stability and function

Roles of CDKN1B in cancer?

STAT3 in Breast Cancer Onset and Progression: A Matter of Time and Context

SUMOylation regulates p27Kip1 stability and localization in response to TGFβ.

Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition.

Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells

Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity

Stathmin Is Required for Normal Mouse Mammary Gland Development and Δ16HER2-Driven Tumorigenesis

Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.

Stathmin is dispensable for tumor onset in mice

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer.

Stathmin: a protein with many tasks. New biomarker and potential target in cancer

Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding

The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition.

Thromboxane A2 synthase activity in platelet free human monocytes

Time-tuning cancer therapy.

USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability

p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion

p27(kip1) functional regulation in human cancer: a potential target for therapeutic designs.

p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis.

p27kip1 at the crossroad between actin and microtubule dynamics

p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability.

p27kip1 expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanisms.

p27kip1: An all-round tumor suppressor

p70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation.